Published • loading... • Updated
Insilico, Qilu Pharmaceutical Sign Deal for Cardiometabolic Therapies
Summary by Pharmaceutical-technology.com
4 Articles
4 Articles
Insilico and Qilu Pharmaceutical sign deal for cardiometabolic therapies
Insilico Medicine has entered a strategic partnership with Qilu Pharmaceutical to develop treatments for cardiometabolic diseases.The post Insilico and Qilu Pharmaceutical sign deal for cardiometabolic therapies appeared first on Hospital Management.
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium